Previous 10 | Next 10 |
Image source: The Motley Fool. AVANTOR (NYSE: AVTR) Q2 2020 Earnings Call Jul 29, 2020 , 5:00 p.m. ET Operator Continue reading
Avantor (NYSE: AVTR ) : Q2 Non-GAAP EPS of $0.19 beats by $0.05 ; GAAP EPS of $0.08 beats by $0.03 . More news on: Avantor, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
RADNOR, Pa. , July 29, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today reported financial results for the second ...
Source : ClearBridge Investments Editor's Note : The summary bullets for this article were chosen by Read more ...
Avantor (NYSE: AVTR ) has priced its private offering of $1.55B (from $1.00B) 4.625% senior notes due 2028 and €400M of 3.875% senior notes due 2028 at par. More news on: Avantor, Inc., Healthcare stocks news, , Read more ...
RADNOR, Pa. , July 7, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today the pricing of the previou...
Avantor (NYSE: AVTR ) expects Q2 revenue in the range of $1.48B - $1.49B vs. consensus of $1.44B, resulting in organic revenue decline of 2% - 3%. More news on: Avantor, Inc., Healthcare stocks news, , Read more ...
Avantor Funding, a wholly-owned subsidiary of Avantor (NYSE: AVTR ) has commenced a private offering of dollar-denominated and euro-denominated senior notes. More news on: Avantor, Inc., Healthcare stocks news, , Read more ...
RADNOR, Pa. , July 7, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, provided preliminary unaudited revenue estimates ...
RADNOR, Pa. , July 7, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today the commencement of a priv...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 07:15:06 ET Barclays analyst issues OVERWEIGHT recommendation for AVTR on July 29, 2024 05:42AM ET. The previous analyst recommendation was Overweight. AVTR was trading at $25.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...
Avantor® Reports Second Quarter 2024 Results PR Newswire Net sales of $1.70 billion , decrease of 2.4%; organic decline of 2.0% Net income of $93 million ; Adjusted EBITDA of $306 million Diluted GAAP EPS of $0.14 ; adjusted EPS of $0.25 Op...